EULAR View-points on SARS-CoV-2 vaccination in patients with RMDs
The COVID-19 pandemic has significantly impacted the care and personal lives of people with Rheumatic and Musculoskeletal diseases (RMDs). Vaccination against COVID-19 has brought optimism and hope but has also raised questions, especially for people with inflammatory RMDs and those receiving drugs that may influence their immune system.